4.7 Review

Interleukin-13 (IL-13)-A Pleiotropic Cytokine Involved in Wound Healing and Fibrosis

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

Zobair M. Younossi et al.

Summary: A comprehensive meta-analysis was conducted to assess the global and regional prevalence, incidence, and mortality of non-alcoholic fatty liver disease (NAFLD). The results showed that the global prevalence of NAFLD is 30% and increasing, highlighting the need for urgent and comprehensive strategies to raise awareness and address NAFLD on local, regional, and global levels.

HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Clinical characteristics of patients with non-alcoholic fatty liver disease (NAFLD) in Germany - First data from the German NAFLD-Registry

Andreas Geier et al.

Summary: The German NAFLD-Registry is a prospective study that aims to describe clinical characteristics and observe outcomes in patients with NAFLD. From the baseline data of the first 501 patients, it was found that approximately 13% had a high risk for advanced fibrosis, about one-third had a liver stiffness value greater than 9.6kPa, and 10% had a clinical diagnosis of liver cirrhosis. Comorbidities such as arterial hypertension, hypercholesterolemia, and type 2 diabetes mellitus were more prevalent in high-risk patients.

ZEITSCHRIFT FUR GASTROENTEROLOGIE (2023)

Article Gastroenterology & Hepatology

The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States

Zobair M. Younossi et al.

Summary: This study modeled the burden of NASH in the United States according to obesity and found that there is a substantial and growing clinical and economic burden of NASH in the country.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

A multi-society Delphi consensus statement on new fatty liver disease nomenclature

Mary E. Rinella et al.

Annals of Hepatology (2023)

Article Biochemistry & Molecular Biology

Antifibrotic Drug Nintedanib Inhibits CSF1R to Promote IL-4-associated Tissue Repair Macrophages

Carolin K. Watson et al.

Summary: This study aims to identify the phenotypes of profibrotic and prohomeostatic macrophages and discover new therapeutic approaches for fibrotic disease. By combining in vivo and in vitro RNA-sequencing methods, the study found that nintedanib can promote the expression of IL-4/IL-13 pathway genes in lung macrophages, leading to tissue repair.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2023)

Article Gastroenterology & Hepatology

Plasticity between type 2 innate lymphoid cell subsets and amphiregulin expression regulates epithelial repair in biliary atresia

Abigail E. Russi et al.

Summary: This study investigates the mechanisms by which different subpopulations of type 2 innate lymphoid cells (ILC2s) regulate the response of biliary epithelial cells to injury. The results demonstrate that natural ILC2s are positively associated with cholangiocyte abundance and that they promote epithelial proliferation through the IL-13/IL-4Rα/STAT6 pathway. This pathway plays a crucial role in maintaining epithelial homeostasis and promoting repair in experimental biliary atresia.

HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Identification and characterization of a hepatic IL-13-producing ILC3-like population potentially involved in liver fibrosis

Jan Raabe et al.

Summary: In this study, researchers performed a detailed characterization of intrahepatic innate lymphoid cells (ILCs) in healthy and fibrotic livers, and identified a previously undescribed subset of ILC3-like cells that produce IL-13. These cells were enriched in human liver and increased in fibrotic livers. IL-13 production by ILC3 induced proinflammatory gene upregulation in hepatic stellate cells, suggesting a potential role in the modulation of chronic liver disease.

HEPATOLOGY (2023)

Review Immunology

Engineering the IL-4/IL-13 axis for targeted immune modulation

Zachary J. J. Bernstein et al.

Summary: IL-4 and IL-13 cytokines play important roles in immune activity, especially in T helper 2 cell-mediated inflammation, immune regulation, antibody production, and fibrosis. Manipulating the IL-4/IL-13 axis through cytokine engineering, fusion protein formulation, antagonist development, cell engineering, and biosensor design can lead to the discovery of new immunotherapies targeting allergy, autoimmune diseases, and cancer.

IMMUNOLOGICAL REVIEWS (2023)

Article Biochemistry & Molecular Biology

Role of the IL-33/ST2 Activation Pathway in the Development of the Hepatic Fibrosis Induced by Schistosoma mansoni Granulomas in Mice

Laura Maggi et al.

Summary: S. mansoni eggs induce cytokine release and granuloma formation, which is inhibited by IL-33/ST2 pathway. Disruption of this pathway results in disorganized granulomas and reduced collagen formation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

The Role of IL-13 and IL-4 in Adipose Tissue Fibrosis

Lilli Arndt et al.

Summary: White adipose tissue fibrosis is strongly associated with inflammation and dysfunction due to obesity. IL-13 and IL-4 have been identified as critical mediators in fibrotic diseases, but their role in WAT fibrosis is still unclear.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cell Biology

Interleukin-13 contributes to the occurrence of oral submucosal fibrosis

Liping Wang et al.

Summary: Oral submucous fibrosis (OSF) is a chronic progressive fibrosis disease that affects the oral mucosal tissues. The study investigates the role of interleukin (IL)-13 in OSF and whether it regulates the polarization of M2-macrophages. High expression of M2-macrophages and IL-13 protein was observed in OSF tissues, and there was a correlation between IL-13 expression and the stage of OSF. Arecoline was found to stimulate fibroblasts and increase IL-13 secretion, which in turn promotes the polarization of M2-macrophages and the occurrence of OSF.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2023)

Article Medicine, Research & Experimental

IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK/STAT6 activation

Hua Chao et al.

Summary: Keloids are a type of fibroproliferative disease characterized by chronic inflammation following skin injury. This study found that more M2 subtype macrophages were activated in keloid dermis compared to normal dermis. It also revealed that keloid fibroblasts had higher levels of phosphorylated STAT6 (p-STAT6), a known inducer of M2 polarization, and lower levels of IL-13RA2, a decoy receptor for IL-13, compared to fibroblasts from normal dermis. Ectopic expression of IL-13RA2 inhibited STAT6 phosphorylation and various cellular processes associated with keloid formation.

JCI INSIGHT (2023)

Article Gastroenterology & Hepatology

A global action agenda for turning the tide on fatty liver disease

Jeffrey V. Lazarus et al.

Summary: Fatty liver disease is a major public health threat, and focused interventions are urgently needed. A consensus-driven action agenda has been developed, which includes 29 priorities such as early diagnosis, addressing the needs of patients with multiple morbidities, and incorporating fatty liver disease into non-communicable disease strategies and guidance.

HEPATOLOGY (2023)

Article Neurosciences

Altered Fear Behavior in Aeroallergen House Dust Mite Exposed C57Bl/6 Mice: A Model of Th2-skewed Airway Inflammation

E. Allgire et al.

Summary: There is a growing interest in studying the impact of chronic inflammation, especially lung inflammation, on the brain and behavior. This study investigated the effects of Th2-skewed airway inflammation on fear extinction in mice and found that it may promote fear extinction, highlighting beneficial interactions with fear regulatory circuits.

NEUROSCIENCE (2023)

Article Biochemistry & Molecular Biology

Eosinophils participate in modulation of liver immune response and tissue damage induced by Schistosoma mansoni infection in mice

Vinicius Gustavo de Oliveira et al.

Summary: The severity of chronic schistosomiasis is associated with the inflammation induced by egg-secreted antigens. Eosinophils play a role in the pathology of schistosomiasis, and their absence leads to changes in liver immune response and tissue damage.

CYTOKINE (2022)

Review Gastroenterology & Hepatology

Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review

Elke Roeb

Summary: The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing, with a strong association with obesity and the metabolic syndrome. Nonalcoholic steatohepatitis (NASH) can progress to advanced fibrosis and cirrhosis, leading to increased all-cause mortality. Currently, there are no approved liver-specific drug therapies for NAFLD in patients without diabetes mellitus, but ongoing clinical studies are investigating potential treatments such as obeticholic acid and acetyl-CoA carboxylase inhibitors. Weight loss, physical training, and the management of risk factors remain key components of NAFLD therapy, with drugs like glucagon-like peptide 1 analogs and sodium-dependent glucose transporter 2 inhibitors showing promise in patients with diabetes and NASH.

VISCERAL MEDICINE (2022)

Article Multidisciplinary Sciences

Liver group 2 innate lymphoid cells regulate blood glucose levels through IL-13 signaling and suppression of gluconeogenesis

Masanori Fujimoto et al.

Summary: This study reveals the involvement of innate lymphoid cells (ILC2s) in regulating blood glucose levels in the liver through their interaction with specific hepatocytes. The ILC2s suppress gluconeogenesis and maintain glucose homeostasis via Interleukin-13 signaling. The findings provide insights into the important role and molecular mechanism of liver ILC2s in glucose metabolism.

NATURE COMMUNICATIONS (2022)

Article

Role of IL-17A in enhancing liver fibrosis induced by TGF-β1 and IL-13 in Schistosoma mansoni infected mice

Mohamed Abd Allah et al.

The Egyptian journal of immunology / Egyptian Association of Immunologists (2022)

Article Pediatrics

IL13 and periostin in active fibrogenic areas of the extrahepatic bile ducts in biliary atresia patients

Yuki Sengoku et al.

Summary: IL13 is associated with induced periostin expression by fibroblasts, playing a vital role in the pathogenesis of fibrogenesis around the extrahepatic bile duct in BA.

PEDIATRIC SURGERY INTERNATIONAL (2022)

Article Materials Science, Biomaterials

Destructive fibrotic teamwork: how both microenvironment stiffness and profibrotic interleukin 13 impair alveolar macrophage phenotype and function

Kartik Bomb et al.

Summary: The pulmonary fibrotic microenvironment, characterized by increased tissue stiffness and enhanced secretion of profibrotic factors, hinders immune cell response, especially macrophages. Through experimental design, it was found that both tissue stiffness and IL13 independently influence macrophage function, but their combined effects exacerbate macrophage impairment, leading to difficulty in clearing debris and promoting fibrosis progression. These findings shed light on how underlying drivers of fibrosis modulate immune cell response and inform potential therapeutic strategies.

BIOMATERIALS SCIENCE (2022)

Article Immunology

IL-13 Controls IL-33 Activity through Modulation of ST2

Melvin Zhang et al.

Summary: IL-13 regulates the activity of IL-33 by modulating the transmembrane and soluble forms of ST2, impacting the responsiveness to IL-33. IL-13-deficient mice showed exacerbated effects following IL-33 administration, highlighting the important regulatory role of IL-13 on IL-33.

JOURNAL OF IMMUNOLOGY (2021)

Article Medicine, Research & Experimental

Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection

Sui-Weng Wong et al.

Summary: This study investigates the pathogenesis of NAFLD in patients with chronic HBV infection and reveals the correlation between liver function markers and NAFLD as well as liver fibrosis. IL-13 and CCL11 play crucial roles in linking metabolic syndrome, chronic inflammation, and progression of liver cirrhosis in CHB patients.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2021)

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach

Mercedes Perez-Carreras et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease, increasing prevalence in parallel with obesity and type 2 diabetes mellitus epidemics. Recent studies suggest NAFLD may be a hepatic manifestation of a systemic inflammatory metabolic disease affecting other organs, with pathogenic mechanisms including proinflammatory/anti-inflammatory cytokine imbalance, insulin resistance, and changes in intestinal microbiota. The presence of extrahepatic diseases like inflammatory bowel disease (IBD), obstructive sleep apnea (OSA), and psoriasis may impact the severity of liver lesions in NAFLD patients, with specific risk characteristics identified in these populations.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Review Immunology

The Genetics of Human Schistosomiasis Infection Intensity and Liver Disease: A Review

Estelle M. Mewamba et al.

Summary: This review focuses on how genetic factors may influence parasite load, hepatic fibrosis and portal hypertension in schistosomiasis. Studies have shown a potential role for the T(h)17 pathway genes in controlling infection intensity and pathology. Future studies should prioritize investigating the effects of variants in this pathway on regulating these phenotypes.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis

Dan J. K. Yombo et al.

Summary: The study revealed that the IL-31/IL-31RA signaling pathway plays a pathogenic role in bleomycin-induced pulmonary fibrosis, and deficiency of IL-31RA can attenuate collagen deposition and decline in lung function, providing a new therapeutic target for pulmonary fibrosis.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

Non-alcoholic fatty liver diseases: current challenges and future directions

Elke Roeb

Summary: Non-alcoholic fatty liver diseases (NAFLD) is rapidly becoming the most common cause of chronic liver disease in Western countries, with a lack of non-invasive diagnostic tools and approved drugs for treatment. Management strategies and prevention of risk factors through weight reduction and exercise remain crucial in addressing NAFLD.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Integrative & Complementary Medicine

Genistein and exercise treatment reduced NASH related HDAC3, IL-13 and MMP-12 expressions in ovariectomized rats fed with high fat high fructose diet

Namthip Witayavanitkul et al.

Summary: The study found that genistein and exercise treatments improved non-alcoholic steatohepatitis by suppressing the expression of specific proteins. However, the combination therapy did not provide additional benefits.

JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE (2021)

Review Dermatology

The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets

Julie K. Nguyen et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2020)

Article Endocrinology & Metabolism

Interleukin-13 ameliorates postischemic hepatic gluconeogenesis and hyperglycemia in rat model of stroke

Keng-Ying Liao et al.

METABOLIC BRAIN DISEASE (2020)

Article Biochemistry & Molecular Biology

IL-13 signaling through IL-13 receptor 2 mediates airway epithelial wound repair

S. Jasemine Yang et al.

FASEB JOURNAL (2019)

Review Pharmacology & Pharmacy

The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma

Giancarlo Marone et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Immunology

Emerging Role of HMGB1 in the Pathogenesis of Schistosomiasis Liver Fibrosis

Amanda R. R. Vicentino et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Cell Biology

Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β

Kevin M. Hart et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Article Biotechnology & Applied Microbiology

Effects of IL-13 on TGF-β and MMP-1 in periodontitis

A. Beklen

BIOTECHNIC & HISTOCHEMISTRY (2017)

Review Biochemistry & Molecular Biology

Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment

Meric Erikci Ertunc et al.

JOURNAL OF LIPID RESEARCH (2016)

Review Gastroenterology & Hepatology

Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis

Nada Pejnovic et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Biochemistry & Molecular Biology

Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis B

Zhiqing Yang et al.

INNATE IMMUNITY (2015)

Article Endocrinology & Metabolism

Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice

P. Darkhal et al.

INTERNATIONAL JOURNAL OF OBESITY (2015)

Review Dermatology

Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis

R. Candia et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)

Article Microbiology

Silymarin Reduces Profibrogenic Cytokines and Reverses Hepatic Fibrosis in Chronic Murine Schistosomiasis

Hilton Antonio Mata-Santos et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

Article Cardiac & Cardiovascular Systems

Interleukin-13 Deficiency Aggravates Healing and Remodeling in Male Mice After Experimental Myocardial Infarction

Ulrich Hofmann et al.

CIRCULATION-HEART FAILURE (2014)

Article Medicine, Research & Experimental

Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation

Jun Li et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Medicine, Research & Experimental

Direct control of hepatic glucose production by interleukin-13 in mice

Kristopher J. Stanya et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Biochemistry & Molecular Biology

The Interleukin 13 (IL-13) Pathway in Human Macrophages Is Modulated by MicroRNA-155 via Direct Targeting of Interleukin 13 Receptor α1 (IL13Rα1)

Rocio T. Martinez-Nunez et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Genetics & Heredity

Population-Based Genome-wide Association Studies Reveal Six Loci Influencing Plasma Levels of Liver Enzymes

Xin Yuan et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2008)

Article Gastroenterology & Hepatology

Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection

Jun-ping Shi et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)

Article Medicine, Research & Experimental

ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo

PJ Lee et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Biochemistry & Molecular Biology

IL-13 signaling through the IL-13 alpha 2 receptor is involved in induction of TGF-beta 1 production and fibrosis

S Fichtner-Feigl et al.

NATURE MEDICINE (2006)

Article Gastroenterology & Hepatology

Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells

R Sugimoto et al.

LIVER INTERNATIONAL (2005)

Review Immunology

Opposing roles for IL-13 and IL-13 receptor α2 in health and disease

MM Mentink-Kane et al.

IMMUNOLOGICAL REVIEWS (2004)

Article Cell Biology

Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-γ

M Ahdieh et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)

Article Immunology

CD40L-Induced IL-12 production is further enhanced by the Th2 cytokines IL-4 and IL-13

DMA Bullens et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)

Article Immunology

Expression and contribution of endogenous IL-13 in an experimental model of sepsis

A Matsukawa et al.

JOURNAL OF IMMUNOLOGY (2000)